StockClub

SNOA

SNOASonoma Pharmaceuticals, Inc.$ --
Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc.

SNOA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q4
Revenue
6M USD
YoY +48.1%
Operating Income
-0M USD
YoY +46.5%
Net Income
-1M USD
YoY +25.1%
EPS
-0.33$
YoY +47.6%

Revenue

$19.5M
FY2025 Q1$3.4M
$3.4M
Q1
FY2025 Q2$7M
$7M
Q2
FY2025 Q3$10.5M
$10.5M
Q3
FY2025 Q4$14.3M
$14.3M
Q4
FY2026 Q1$4M
$4M
Q1
FY2026 Q2$9.6M
$9.6M
Q2
FY2026 Q3$14M
$14M
Q3
FY2026 Q4$19.5M
$19.5M
Q4
Actual
+$5.2M (+36.7%)

Net Income

$-3.2M
FY2025 Q1$-1.1M
$-1.1M
Q1
FY2025 Q2$-1.8M
$-1.8M
Q2
FY2025 Q3$-2.7M
$-2.7M
Q3
FY2025 Q4$-3.5M
$-3.5M
Q4
FY2026 Q1$-1.2M
$-1.2M
Q1
FY2026 Q2$-1.8M
$-1.8M
Q2
FY2026 Q3$-2.6M
$-2.6M
Q3
FY2026 Q4$-3.2M
$-3.2M
Q4
Actual
+$282,000 (+8.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021MISS
Actual:$18.6M
Est:$29.9M
FY2021MISS
$18.6M
FY2022MISS
Actual:$12.6M
Est:$37.1M
FY2022MISS
$12.6M
FY2023MISS
Actual:$13.3M
Est:$13.6M
FY2023MISS
$13.3M
FY2024MISS
Actual:$12.7M
Est:$14.6M
FY2024MISS
$12.7M
FY2025MISS
Actual:$14.3M
Est:$15.5M
FY2025MISS
$14.3M
FY2026MISS
Actual:$19.5M
Est:$20.7M
FY2026MISS
$19.5M

Analyst Estimates